Association of serum 25-hydroxyvitamin D with cardiovascular mortality and kidney outcome in patients with early stages of CKD DOI
Yu Lin, Changchun Xie, Yongfeng Zhang

et al.

Journal of Endocrinological Investigation, Journal Year: 2024, Volume and Issue: 47(11), P. 2745 - 2755

Published: May 11, 2024

Language: Английский

Renin–angiotensin system inhibitors and risk of hepatocellular carcinoma among patients with hepatitis B virus infection DOI Creative Commons
Ruixuan Chen, Shiyu Zhou,

Jiao Liu

et al.

Canadian Medical Association Journal, Journal Year: 2024, Volume and Issue: 196(27), P. E931 - E939

Published: Aug. 11, 2024

Hepatitis B virus (HBV) infection is a common cause of liver-related morbidity and mortality. Evidence suggests that angiotensin-converting enzyme inhibitors (ACEIs) angiotensin II receptor blockers (ARBs) decrease liver fibrosis, an intermediate step between injury hepatocellular carcinoma (HCC). Our aim was to investigate the association use ACEIs ARBs on incident HCC mortality among patients with HBV infection.

Language: Английский

Citations

1
The association between serum complement 4 and relapse of primary membranous nephropathy: a multicenter retrospective cohort study DOI Creative Commons
Wenyuan Gan, Fan Zhu, Xingruo Zeng

et al.

Frontiers in Medicine, Journal Year: 2024, Volume and Issue: 11

Published: Nov. 11, 2024

Relapse after initial remission reduces renal survival in patients with primary membranous nephropathy (PMN). In this study, we aim to identify risk factors of relapse PMN and construct a model at high early.

Language: Английский

Citations

1
Inflammation-based scores predict chronic kidney disease progression in patients with chronic kidney disease and chronic heart failure DOI Creative Commons

Lu Cai,

Licong Su, Ying Hu

et al.

Renal Failure, Journal Year: 2024, Volume and Issue: 46(2)

Published: Nov. 26, 2024

Background Inflammation is associated with adverse outcomes of chronic kidney disease (CKD) or heart failure (CHF), but few large data exist. We aimed to explore the clinical associations, and prognostic consequences inflammation-based scores in patients CKD CHF.

Language: Английский

Citations

1
Cardiovascular effectiveness of newer glucose-lowering agents, with and without baseline lipid-lowering therapy in type 2 diabetes: A systematic meta-analysis of cardiovascular outcome trials and real-world evidence DOI Creative Commons
Setor K. Kunutsor,

Borenyi S. Seidu,

Samuel Seidu

et al.

Primary care diabetes, Journal Year: 2024, Volume and Issue: 18(6), P. 589 - 598

Published: Oct. 3, 2024

Whether the cardiovascular treatment benefits of sodium-glucose co-transporter 2 inhibitors (SGLT-2is) and glucagon-like peptide 1 receptor agonists (GLP-1RAs) differ by baseline use statins/lipid lowering therapy is unclear. This systematic review meta-analysis investigated whether statin (users vs non-users) influences kidney SGLT-2is GLP-1RAs in patients with type diabetes (T2D).

Language: Английский

Citations

0
Association of serum 25-hydroxyvitamin D with cardiovascular mortality and kidney outcome in patients with early stages of CKD DOI
Yu Lin, Changchun Xie, Yongfeng Zhang

et al.

Journal of Endocrinological Investigation, Journal Year: 2024, Volume and Issue: 47(11), P. 2745 - 2755

Published: May 11, 2024

Language: Английский

Citations

0